(a) In order to ensure the public health and safety, an authorized entity that acquires auto-injectable epinephrine shall ensure that:

1. (1) An expected user:

   1. (A) Completes appropriate knowledge and skills courses at least one (1) time every two (2) years in anaphylaxis and auto-injectable epinephrine use; and
   2. (B) Obtains a certificate under the Insect Sting and Other Allergic Reactions Emergency Treatment Act, Arkansas Code § 20-13-401 et seq.;
2. (2) The auto-injectable epinephrine is maintained according to the manufacturer's operational guidelines and instructions in a locked, secure location; and
3. (3) A person who renders emergency care or treatment to a person having an anaphylactic reaction by using auto-injectable epinephrine activates the emergency medical services system as soon as possible and immediately reports the use of auto-injectable epinephrine to the medical provider responding to the emergency.

(b) An authorized entity and its expected users may:

1. (1) Obtain a prescription in the name of the authorized entity for epinephrine auto-injectors and acquire epinephrine auto-injectors under the prescription;
2. (2) Provide auto-injectable epinephrine for immediate self-administration to an individual who the authorized entity or expected user believes in good faith is experiencing anaphylaxis, regardless of whether the individual has a prescription for auto-injectable epinephrine or has previously been diagnosed with an allergy; and
3. (3) Administer auto-injectable epinephrine directly to an individual who the authorized entity or expected user believes in good faith is experiencing anaphylaxis, regardless of whether the individual has a prescription for auto-injectable epinephrine or has been previously diagnosed with an allergy.

(c) An authorized entity that possesses and makes available auto-injectable epinephrine shall:

1. (1)

   1. (A) Submit to the Department of Health a report of each incident on the authorized entity's premises in which the authorized entity provides or administers auto-injectable epinephrine.
   2. (B) The report shall include the following:

(i) The name and address of the authorized entity;

1. (ii) The name and certificate number of the person administering auto-injectable epinephrine;

   1. (iii) The age of the person receiving the injection; and

      1. (iv)

(b) (b) The department shall annually publish a report that summarizes and analyzes the reports submitted under this subdivision (c)(1); and

1. (2) Notify an agent of emergency communications, 911, or vehicle dispatch center of the existence, location, and type of auto-injectable epinephrine.